JNK pathway-associated phosphatase associates with rheumatoid arthritis risk, disease activity, and its longitudinal elevation relates to etanercept treatment response.

MLA

Sun, Li, et al. “JNK Pathway-Associated Phosphatase Associates with Rheumatoid Arthritis Risk, Disease Activity, and Its Longitudinal Elevation Relates to Etanercept Treatment Response.” Journal of Clinical Laboratory Analysis, vol. 35, no. 4, Apr. 2021, p. e23709. EBSCOhost, https://doi.org/10.1002/jcla.23709.

APA

Sun, L., Tu, J., Chen, X., Dai, M., Xia, X., Liu, C., & Zhou, Y. (2021). JNK pathway-associated phosphatase associates with rheumatoid arthritis risk, disease activity, and its longitudinal elevation relates to etanercept treatment response. Journal of Clinical Laboratory Analysis, 35(4), e23709. https://doi.org/10.1002/jcla.23709

Chicago

Sun, Li, Jianxin Tu, Xiaowei Chen, Meijie Dai, Xiaoru Xia, Cailong Liu, and Yan Zhou. 2021. “JNK Pathway-Associated Phosphatase Associates with Rheumatoid Arthritis Risk, Disease Activity, and Its Longitudinal Elevation Relates to Etanercept Treatment Response.” Journal of Clinical Laboratory Analysis 35 (4): e23709. doi:10.1002/jcla.23709.